Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis

Improved vectors and genome-wide libraries for CRISPR screening

Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836

Myofibroblasts and mechano-regulation of connective tissue remodelling

Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290

Succinate is an inflammatory signal that induces IL-1β through HIF-1α

Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation

DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905

Otto Warburg's contributions to current concepts of cancer metabolism

Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427

Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233

Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation

Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057

The Myofibroblast

Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068

Role of PFKFB3-driven glycolysis in sepsis

Xiao, M., Liu, D., Xu, Y., Mao, W., & Li, W. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2191217 · Cited by 64

Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets

Mericskay, M., Zuurbier, C. J., Heather, L. C., Karlstaedt, A., Inserte, J., Bertrand, L., Kararigas, G., Ruiz‐Meana, M., Maack, C., & Schiattarella, G. G. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01166-7 · Cited by 68

Metabolic reprogramming in keloid fibroblasts: Aerobic glycolysis and a novel therapeutic strategy

Li, Q., Qin, Z., Nie, F., Bi, H., Zhao, R., Pan, B., Ma, J., & Xie, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.068 · Cited by 65

Parallel Murine and Human Aortic Wall Genomics Reveals Metabolic Reprogramming as Key Driver of Abdominal Aortic Aneurysm Progression

Gäbel, G., Northoff, B. H., Ramilo, A. B., Becirovic‐Agic, M., Petri, M. H., Busch, A., Mäegdefessel, L., Mahlmann, A., Ludwig, S., Teupser, D., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020231 · Cited by 63

Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases

Shi, N., Wang, Z., Zhu, H., Liu, W., Zhao, M., Jiang, X., Zhao, J., Ren, C., Zhang, Y., & Luo, L. (2022) · Immunologic Research · doi:10.1007/s12026-022-09267-y · Cited by 71

Comprehensive review of potential drugs with anti-pulmonary fibrosis properties

Ma, J., Li, G., Wang, H., & Mo, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116282 · Cited by 63

Sirtuins as endogenous regulators of lung fibrosis: A current perspective

Mazumder, S., Barman, M., Bandyopadhyay, U., & Bindu, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118201 · Cited by 61

Metabolic control of collagen synthesis

Guillard, J., & Schwörer, S. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.07.003 · Cited by 61

Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients

Bondue, B., Castiaux, A., Simaeys, G. V., Mathey, C., Sherer, F., Egrise, D., Lacroix, S., Huaux, F., Doumont, G., & Goldman, S. (2019) · Respiratory Research · doi:10.1186/s12931-019-0974-5 · Cited by 61

Metabolic Regulation of Fibroblast Activation and Proliferation during Organ Fibrosis

Wang, S., Liang, Y., & Dai, C. (2022) · Kidney Diseases · doi:10.1159/000522417 · Cited by 60

Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge

Effendi, W. I., & Nagano, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116064 · Cited by 60

Thermodynamic Aspects and Reprogramming Cellular Energy Metabolism during the Fibrosis Process

Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122537 · Cited by 61

Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis

Renaud, L., da Silveira, W. A., Takamura, N., Hardiman, G., & Feghali‐Bostwick, C. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00383 · Cited by 59

Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung

Yan, P., Liu, J., Li, Z., Wang, J., Zhu, Z., Wang, L., & Yu, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010315 · Cited by 68

Circadian Rhythms in Cardiovascular Metabolism

Lal, H., Verma, S. K., Wang, Y., Xie, M., & Young, M. E. (2024) · Circulation Research · doi:10.1161/circresaha.123.323520 · Cited by 67

Bioactive Plasma Mitochondrial DNA Is Associated With Disease Progression in Scleroderma‐Associated Interstitial Lung Disease

Ryu, C., Walia, A., Ortiz, V., Perry, C., Woo, S., Reeves, B. C., Sun, H., Winkler, J., Kanyo, J. E., Wang, W., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41418 · Cited by 61

Alamandine/MrgD axis prevents TGF-β1-mediated fibroblast activation via regulation of aerobic glycolysis and mitophagy

Wang, W., Zhang, Y., Huang, W., Yuan, Y., Hong, Q., Xie, Z., Li, L., Chen, Y., Li, X., & Meng, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-022-03837-2 · Cited by 58

Polylactide Degradation Activates Immune Cells by Metabolic Reprogramming

Maduka, C. V., Alhaj, M., Ural, E. E., Habeeb, O. M., Kuhnert, M. M., Smith, K. R., Makela, A. V., Pope, H., Chen, S., Hix, J. M. L., et al. (2023) · Advanced Science · doi:10.1002/advs.202304632 · Cited by 61

Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol

Judge, J., Nagel, D. J., Owens, K. M., Rackow, A. R., Phipps, R. P., Sime, P. J., & Kottmann, R. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197936 · Cited by 59

Metabolic Reprogramming as a Driver of Fibroblast Activation in PulmonaryFibrosis

Para, R., Romero, F., George, G., & Summer, R. S. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.02.003 · Cited by 62

Metabolic Disorders in Chronic Lung Diseases

Παπαϊωάννου, Ο., Karampitsakos, Τ., Barbayianni, I., Chrysikos, S., Xylourgidis, N., Tzilas, V., Bouros, D. E., Aidinis, V., & Tzouvelekis, A. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2017.00246 · Cited by 58

Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis

Vukmirovic, M., & Kaminski, N. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00087 · Cited by 56

Metabolic reprogramming of pulmonary fibrosis

Li, J., Zhai, X., Sun, X., Cao, S., Yuan, Q., & Wang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1031890 · Cited by 63

Metabolic perturbations in fibrosis disease

Ung, C. Y., Onoufriadis, A., Parsons, M., McGrath, J. A., & Shaw, T. J. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106073 · Cited by 55

Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury

Rao, X., Zhou, D., Deng, H., Chen, Y., Wang, J., Zhou, X., Jie, X., Xu, Y., Wu, Z., Wang, G., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02331-7 · Cited by 57

Myofibroblast fate plasticity in tissue repair and fibrosis: Deactivation, apoptosis, senescence and reprogramming

Merkt, W., Zhou, Y., Han, H., & Lagares, D. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12952 · Cited by 62

Differential Metabotypes in Synovial Fibroblasts and Synovial Fluid in Hip Osteoarthritis Patients Support Inflammatory Responses

Farah, H., Wijesinghe, S. N., Nicholson, T. A., Alnajjar, F., Certo, M., Alghamdi, A., Davis, E. T., Young, S. P., Mauro, C., & Jones, S. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063266 · Cited by 54

METTL3 boosts glycolysis and cardiac fibroblast proliferation by increasing AR methylation

Zhou, Y., Song, K., Tu, B., Sun, H., Ding, J.-F., Luo, Y., Sha, J.-M., Li, R., Ye, Z., Zhao, J., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.042 · Cited by 57

Impact of MicroRNAs in the Cellular Response to Hypoxia

Bertero, T., Rezzonico, R., Pottier, N., & Mari, B. P. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.006 · Cited by 56

The role of metabolic reprogramming and de novo amino acid synthesis in collagen protein production by myofibroblasts: implications for organ fibrosis and cancer

Hamanaka, R. B., & Mutlu, G. M. (2021) · Amino Acids · doi:10.1007/s00726-021-02996-8 · Cited by 54

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

Chen, W., Zhang, J., Zhong, W., Liu, Y., Lu, Y., Zeng, Z., Huang, H., Wan, X., Meng, X., Zou, F., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.744826 · Cited by 53

Spatially Resolved Deconvolution of the Fibrotic Niche in Lung Fibrosis

Eyres, M., Bell, J. A., Davies, E. R., Fabre, A., Alzetani, A., Jogai, S., Marshall, B. G., Johnston, D. A., Xu, Z., Fletcher, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111230 · Cited by 54

Fibrosis: Lessons from OMICS analyses of the human lung

Yu, G., Ibarra, G. H., & Kaminski, N. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.014 · Cited by 52

Tumor metabolic reprogramming in lung cancer progression (Review)

Li, X., Liu, M., Liu, H., & Chen, J. (2022) · Oncology Letters · doi:10.3892/ol.2022.13407 · Cited by 52

The Lactate Dehydrogenase Inhibitor Gossypol Inhibits Radiation-Induced Pulmonary Fibrosis

Judge, J., Lacy, S. H., Ku, W.-Y., Owens, K. M., Hernady, E., Thatcher, T. H., Williams, J. P., Phipps, R. P., Sime, P. J., & Kottmann, R. M. (2017) · Radiation Research · doi:10.1667/rr14620.1 · Cited by 52

Aerobic Glycolysis and the Warburg Effect. An Unexplored Realm in the Search for Fibrosis Therapies?

Maher, T. M. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1699ed · Cited by 54

Metabolic Reprogramming and Renal Fibrosis

Zhu, X., Jiang, L., Long, M., Wei, X. S., Hou, Y., & Du, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.746920 · Cited by 53

Mechanical stress regulates the mechanotransduction and metabolism of cardiac fibroblasts in fibrotic cardiac diseases

Tian, G., & Ren, T. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151288 · Cited by 51

Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis

Lv, J., Gao, H., Ma, J., Liu, J., Tian, Y., Yang, C., Li, M., Zhao, Y., Li, Z., Zhang, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1230266 · Cited by 48

miR-21 in EVs from pulmonary epithelial cells promotes myofibroblast differentiation via glycolysis in arsenic-induced pulmonary fibrosis

Wang, P., Xiao, T., Li, J., Wang, D., Sun, J., Cheng, C., Ma, H., Xue, J., Li, Y., Zhang, A., et al. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117259 · Cited by 49

Small molecule 3PO inhibits glycolysis but does not bind to 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase‐3 (PFKFB3)

Veseli, B. E., Perrotta, P., Wielendaele, P. V., Lambeir, A., Abdali, A., Bellosta, S., Monaco, G., Bultynck, G., Martinet, W., & Meyer, G. R. Y. D. (2020) · FEBS Letters · doi:10.1002/1873-3468.13878 · Cited by 47

Mechanical stiffness promotes skin fibrosis through Piezo1-mediated arginine and proline metabolism

He, J., Fang, B., Shan, S., & Li, Q. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01656-y · Cited by 47

Tissue fibroblasts are versatile immune regulators: An evaluation of their impact on the aging process

Salminen, A., Kaarniranta, K., & Kauppinen, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102296 · Cited by 50

IL-36 induces cytokine IL-6 and chemokine CXCL8 expression in human lung tissue cells: Implications for pulmonary inflammatory responses

Zhang, J., Yin, Y., Lin, X., Yan, X., Xia, Y., Zhang, L., & Cao, J. (2017) · Cytokine · doi:10.1016/j.cyto.2017.08.022 · Cited by 46

Novel Therapeutic Targets in Liver Fibrosis

Zhang, J., Liu, Q., He, J., & Li, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.766855 · Cited by 48

Emerging role for branched-chain amino acids metabolism in fibrosis

Wu, T., Wang, M., Ning, F., Zhou, S., Hu, X., Xin, H., Reilly, S. N., & Zhang, X. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106604 · Cited by 47

Skin fibroblast functional heterogeneity in health and disease

Bensa, T., Tekkela, S., & Rognoni, E. (2023) · The Journal of Pathology · doi:10.1002/path.6159 · Cited by 47

TGF-β1 modifies histone acetylation and acetyl-coenzyme A metabolism in renal myofibroblasts

Smith, E. R., Wigg, B., Holt, S. G., & Hewitson, T. D. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00513.2018 · Cited by 45

Autophagy in pulmonary fibrosis: friend or foe?

Hill, C. N., & Wang, Y. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.09.008 · Cited by 46

Targeting fatty acid metabolism for fibrotic disorders

Hwang, S., & Chung, K. W. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01352-4 · Cited by 47

MYBPC3 deficiency in cardiac fibroblasts drives their activation and contributes to fibrosis

Zou, X., Ouyang, H., Feng, L., Zhang, H., Yang, Y., Pang, D., Han, R., & Tang, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05403-6 · Cited by 46

Regulation of macrophage activation by lactylation in lung disease

Wei, Y., Guo, H., Chen, S., & Tang, X. X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1427739 · Cited by 44

Genetic Alteration in Phosphofructokinase Family Promotes Growth of Muscle-Invasive Bladder Cancer

Sun, C., Xiong, D., Yang, Y., Geng, J., Liu, M., & Yao, X. (2016) · The International Journal of Biological Markers · doi:10.5301/jbm.5000189 · Cited by 44

Metabolic variations in normal and fibrotic human laryngotracheal‐derived fibroblasts: A Warburg‐like effect

Ma, G., Samad, I., Motz, K., Yin, L. X., Duvvuri, M., Ding, D., Namba, D. R., Elisseeff, J. H., Horton, M. R., & Hillel, A. T. (2016) · The Laryngoscope · doi:10.1002/lary.26254 · Cited by 44

Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling

Bhedi, C. D., Nasirova, S., Toksoz, D., Warburton, R. R., Morine, K., Kapur, N. K., Galper, J., Preston, I. R., Hill, N. S., Fanburg, B. L., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201902155r · Cited by 44

Advances in energy metabolism in renal fibrosis

Wei, X. S., Hou, Y., Long, M., Jiang, L., & Du, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121033 · Cited by 44

18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study

Ledoult, E., Morelle, M., Soussan, M., MEKINIAN, A., Béhal, H., Sobanski, V., HACHULLA, E., Huglo, D. G., Gouellec, N. L., Rémy-Jardin, M., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02460-8 · Cited by 44

GLUT-1 Enhances Glycolysis, Oxidative Stress, and Fibroblast Proliferation in Keloid

Lu, Y., Wu, C., Hong, C., Chang, K., & Lee, C. (2021) · Life · doi:10.3390/life11060505 · Cited by 45

Evolving Perspectives on Innate Immune Mechanisms of IPF

Ishikawa, G., Liu, A., & Herzog, E. L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.676569 · Cited by 44

Mapping the metabolomic and lipidomic changes in the bleomycin model of pulmonary fibrosis in young and aged mice

Weckerle, J., Picart‐Armada, S., Klee, S., Bretschneider, T., Luippold, A. H., Rist, W., Haslinger, C., Schlüter, H., Thomas, M. J., Krawczyk, B., et al. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049105 · Cited by 43

Update in Pulmonary Fibrosis 2018

Sgalla, G., Kulkarni, T., Antin-Ozerkis, D. E., Thannickal, V. J., & Richeldi, L. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0542up · Cited by 42

Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells

Zhou, M., Cheng, M., Huang, T., Hu, R.-H., Zou, G.-L., Li, H., Zhang, B., Zhu, J., Liu, Y., Liu, Y., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i40.6908 · Cited by 45

Reciprocal interactions between alveolar progenitor dysfunction and aging promote lung fibrosis

Liang, J., Huang, G., Liu, X., Taghavifar, F., Liu, N., 姚昌富, Deng, N., Wang, Y., Burman, A., Xie, T., et al. (2023) · eLife · doi:10.7554/elife.85415 · Cited by 42

Human lung fibroblast-to-myofibroblast transformation is not driven by an LDH5-dependent metabolic shift towards aerobic glycolysis

Schruf, E., Schroeder, V., Kuttruff, C. A., Weigle, S., Krell, M., Benz, M., Bretschneider, T., Holweg, A., Schuler, M. J., Frick, M., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1058-2 · Cited by 41

ACSS3 regulates the metabolic homeostasis of epithelial cells and alleviates pulmonary fibrosis

Wang, L., Yuan, H., Li, W., Yan, P., Zhao, M., Li, Z., Zhao, H., Wang, S., Wan, R., Li, Y., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166960 · Cited by 40

Network pharmacology combines machine learning, molecular simulation dynamics and experimental validation to explore the mechanism of acetylbinankadsurin A in the treatment of liver fibrosis

Peng, W., Yang, Y., Lu, H., Shi, H., Jiang, L., Liao, X., Zhao, H., Wang, W., & Liu, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117682 · Cited by 40

GPR87 promotes renal tubulointerstitial fibrosis by accelerating glycolysis and mitochondrial injury

Cui, X., Shi, E., Li, J., Li, Y., Qiao, Z., Wang, Z., Liu, M., Tang, W., Sun, Y., Zhang, Y., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.07.004 · Cited by 39

FOXO4 peptide targets myofibroblast ameliorates bleomycin‐induced pulmonary fibrosis in mice through ECM‐receptor interaction pathway

Han, X., Yuan, T., Zhang, J., Shi, Y., Li, D., Dong, Y., & Fan, S. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17333 · Cited by 41

Metformin prevents PFKFB3‑related aerobic glycolysis from enhancing collagen synthesis in lung fibroblasts by regulating AMPK/mTOR pathway

Tang, C., Xu, J. P., Ye, H.-Y., & Wang, X. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10013 · Cited by 39

Integrin β3-PKM2 pathway-mediated aerobic glycolysis contributes to mechanical ventilation-induced pulmonary fibrosis

Mei, S., Xu, Q., Hu, Y., Tang, R. N., Feng, J., Zhou, Y., Xing, S., Gao, Y., & He, Z. (2022) · Theranostics · doi:10.7150/thno.72328 · Cited by 38

The role of metabolism in the pathogenesis of systemic sclerosis

Zhu, H., Chen, W., Liu, D., & Luo, H. (2018) · Metabolism · doi:10.1016/j.metabol.2018.12.004 · Cited by 38

Acylations in cardiovascular biology and diseases, what's beyond acetylation

Sun, X., Zhang, Y., Chen, X., & Tang, X. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104418 · Cited by 38

Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment

Tanaka, H. Y., Nakazawa, T., Enomoto, A., Masamune, A., & Kano, M. R. (2023) · Cancers · doi:10.3390/cancers15030724 · Cited by 42

PFKFB3-Mediated Glycolysis Boosts Fibroblast Activation and Subsequent Kidney Fibrosis

Yang, Q., Huo, E., Cai, Y., Zhang, Z., Dong, C., Asara, J. M., & Wei, Q. (2023) · Cells · doi:10.3390/cells12162081 · Cited by 39

The impact of glucose metabolism on inflammatory processes in sepsis-induced acute lung injury

Cheng, S., Li, Y., Sun, X., Liu, Z., Guo, L., Wu, J., Yang, X., Wei, S., Wu, G., Xu, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1508985 · Cited by 37

Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis

Andreucci, E., Margheri, F., Peppicelli, S., Bianchini, F., Ruzzolini, J., Laurenzana, A., Fibbi, G., Bruni, C., Bellando-Randone, S., Guiducci, S., et al. (2021) · Rheumatology · doi:10.1093/rheumatology/keab022 · Cited by 36

Butyrate Prevents TGF-β1-Induced Alveolar Myofibroblast Differentiation and Modulates Energy Metabolism

Lee, H. Y., Nam, S., Kim, M. J., Kim, S. J., Back, S. H., & Yoo, H. J. (2021) · Metabolites · doi:10.3390/metabo11050258 · Cited by 39

Triiodothyronine ameliorates silica-induced pulmonary inflammation and fibrosis in mice

Yang, M., Wang, D., Gan, S., Wang, B., Yu, L., Xie, Y., Fan, L., Ma, J., & Chen, W. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.148041 · Cited by 37

Increased stromal PFKFB3-mediated glycolysis in inflammatory bowel disease contributes to intestinal inflammation

Zhou, Z., Plug, L. G., Patente, T. A., de Jonge‐Muller, E. S. M., Elmagd, A. A., Jong, A. E. V. D. M., Everts, B., Barnhoorn, M. C., & Hawinkels, L. J. A. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.966067 · Cited by 38

Upregulation of glycolytic enzyme PFKFB3 by deubiquitinase OTUD4 promotes cardiac fibrosis post myocardial infarction

Wang, F., Yin, X., Fan, Y.-M., Zhang, X., Ma, C., Jia, K., Zhou, W., Tang, Z., Qi, L., & Li, J. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02323-6 · Cited by 36

Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma

Bueno, M., Papazoglou, A., Valenzi, E., Rojas, M. M., Lafyatis, R., & Mora, A. L. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00920-9 · Cited by 39

Caveolin-1 scaffolding domain peptide regulates glucose metabolism in lung fibrosis

Gopu, V., Fan, L., Shetty, R. R., Nagaraja, M. R., & Shetty, S. (2020) · JCI Insight · doi:10.1172/jci.insight.137969 · Cited by 35

c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis

Leslie, J., Macia, M. G., Luli, S., Worrell, J. C., Reilly, W. J., Paish, H. L., Knox, A., Barksby, B. S., Gee, L., Zaki, M. Y. W., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00306-2 · Cited by 36

Metabolic reprogramming: A driver of cigarette smoke-induced inflammatory lung diseases

Li, L., Yang, D. C. H., & Chen, C. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.438 · Cited by 39

Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis

Ligresti, G., Raslan, A., Hong, J., Caporarello, N., Confalonieri, M., & Huang, S. K. (2023) · Gene · doi:10.1016/j.gene.2022.147142 · Cited by 40

Stemona alkaloids suppress the positive feedback loop between M2 polarization and fibroblast differentiation by inhibiting JAK2/STAT3 pathway in fibroblasts and CXCR4/PI3K/AKT1 pathway in macrophages

Ding, Q., Sun, J., Xie, W., Zhang, M., Zhang, C., & Xu, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.030 · Cited by 36

Fibrogenic fibroblast-selective near-infrared phototherapy to control scarring

Chen, Z., Wang, Z., Jin, T., Shen, G., Wang, Y., Tan, X., Gan, Y., Yang, F., Liu, Y., Huang, C., et al. (2019) · Theranostics · doi:10.7150/thno.36375 · Cited by 35

Hypoxia in Cancer and Fibrosis: Part of the Problem and Part of the Solution

Romero, Y., & Aquino‐Gálvez, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158335 · Cited by 39

Glycolytic Reprogramming in Silica-Induced Lung Macrophages and Silicosis Reversed by Ac-SDKP Treatment

Mao, N., Yang, H., Yin, J., Li, Y., Jin, F., Li, T. X., Yang, X., Sun, Y., Liu, H., Xu, H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810063 · Cited by 35

Myeloid PFKFB3-mediated glycolysis promotes kidney fibrosis

Yang, Q., Huo, E., Cai, Y., Zhang, Z., Dong, C., Asara, J. M., Shi, H., & Wei, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1259434 · Cited by 34

Neotuberostemonine inhibits the differentiation of lung fibroblasts into myofibroblasts in mice by regulating HIF-1α signaling

Lv, X.-M., Li, M.-D., Cheng, S., Liu, B., Liu, K., Zhang, C., Xu, X., & Zhang, M. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.202 · Cited by 34

Recent developments in the pathobiology of lung myofibroblasts

Jiang, D., Dey, T., & Liu, G. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1829972 · Cited by 34

Mitochondria at Center of Exchanges between Cancer Cells and Cancer-Associated Fibroblasts during Tumor Progression

Nocquet, L., Juin, P. P., & Souazé, F. (2020) · Cancers · doi:10.3390/cancers12103017 · Cited by 34

Orphan nuclear receptor COUP-TFII enhances myofibroblast glycolysis leading to kidney fibrosis

Li, L., Galichon, P., Xiao, X., Figueroa‐Ramirez, A. C., Tamayo, D., Lee, J. J.-K., Kalocsay, M., Gonzalez-Sanchez, D. G., Chancay, M. S., McCracken, K. W., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051169 · Cited by 38

Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies

Feng, L., Chen, X., Huang, Y., Zhang, X., Zheng, S., & Xie, N. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1243675 · Cited by 35

Mitochondrial dysfunction and calcium homeostasis in heart failure: Exploring the interplay between oxidative stress and cardiac remodeling for future therapeutic innovations

Johnson, E., Albakri, J. S., Allemailem, K. S., Sultan, A., Alwanian, W. M., Alrumaihi, F., Almansour, N. M., Aldakheel, F. M., Khalil, F. M. A., Abduallah, A. M., et al. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102968 · Cited by 35

Fatty Acid Oxidation‐Glycolysis Metabolic Transition Affects ECM Homeostasis in Silica‐Induced Pulmonary Fibrosis

Sun, W., Zhou, S., Peng, L., Wang, W., Liu, Y., Wang, T., Cheng, D., Li, Z., Xiong, H., Jia, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202407134 · Cited by 35

NADPH Oxidase Inhibition in Fibrotic Pathologies

Bernard, K. F., & Thannickal, V. J. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8032 · Cited by 34

New Insights into the Implication of Mitochondrial Dysfunction in Tissue, Peripheral Blood Mononuclear Cells, and Platelets during Lung Diseases

Riou, M., Alfatni, A., Charles, A., Andrès, E., Pistea, C., Charloux, A., & Gény, B. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051253 · Cited by 34

[18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach

Tanguy, J., Goirand, F., Bouchard, A., Frenay, J., Moreau, M., Mothes, C., Oudot, A., Helbling, A., Guillemin, M., Bonniaud, P., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05209-2 · Cited by 33

Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis

Goodwin, J., Choi, H., Hsieh, M.-H., Neugent, M. L., Ahn, J., Hayenga, H. N., Singh, P. K., Shackelford, D. B., Lee, I., Shulaev, V., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0186oc · Cited by 172

PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis

Hu, X., Xu, Q., Wan, H., Hu, Y., Xing, S., Yang, H., Gao, Y., & He, Z. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0404-9 · Cited by 247

Glycolytic Enzymes as Drivers of Tissue Fibrosis: Metabolic Reprogramming, Lactate Signaling, and Fibrotic Niche Formation

Qiu, H., Siao, C., Yu, L., Qichen, Y., Wuji, D., Xinyu, Z., Yuan, C., & Chang, L. (2026) · Fibrosis · doi:10.70322/fibrosis.2026.10012

Glucose metabolism in idiopathic pulmonary fibrosis

Azuelos, I. (2020) · UCL Discovery (University College London) · Cited by 1

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

Chen, W., Zhang, J., Zhong, W., Liu, Y., Lu, Y., Zeng, Z., Huang, H., Wan, X., Meng, X., Zou, F., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.744826 · Cited by 53